Reimbursement

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the February 2026 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Favourable opinions were issued on the add-on reimbursement for six new devices and on the extension of indications for two devices, in the cardiovascular, peripheral vascular, and ENT fields.

On February 13, 2026, the Ministry of Health published an experimental version (so-called "Gamma") of new classification systems for diagnosis and procedure coding under the NSIS-CLASS project, launching the transition from ICD-9-CM. These systems will become mandatory for coding diagnoses and procedures from January 1, 2027, following a testing phase and the release of the final (“Delta”) versions by the end of 2026, with updates planned at least every two years.

A new version of the Nomenclature of Medical Biology Procedures (NABM 102), effective from March 3, 2026, was published in France. Changes include the introduction of one new code and the deletion and modification of several codes.

In Germany, digital health applications (DiGAs) that can be prescribed by physicians and psychotherapists and reimbursed by statutory health insurers are listed in the Directory of Digital Health Applications maintained by the Federal Institute for Drugs and Medical Devices (BfArM). As of February 23, 2026, a total of 61 apps are available in the Directory and thus eligible for reimbursement.

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the January 2026 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). A favourable opinion was issued on the add-on reimbursement for one new device, as well as on the extension of indications for two devices for transcatheter aortic valve implantation.

On January 13, 2026, a new version of the Nomenclature of Medical Biology Procedures (NABM 101) was published in France. A new chapter for constitutional genetics was introduced, including two new codes.

On January 14, 2026, the French Ministry of Health, Family, Autonomy and People with Disability published the Order setting DRG tariffs and tariffs for other packages and supplements for 2026. The released tariffs are in effect from January 1, 2026, and include new, higher DRG tariffs for several procedures, such as HIFU destruction of prostate lesions, as well as updates to packages for organ perfusion technologies for transplantation.

On December 19, 2025, the Dutch Healthcare Authority (NZa) published the draft release of the 2027 DRG package (RZ27a). Seven new procedure codes, one new diagnosis code, and one new supplementary payment (OZP) are expected to be implemented across in-vitro diagnostics, obstetrics and gynecology, gastroenterology, urology, and other technology groups.

In January 2026, the National Institute for Health and Disability Insurance (INAMI-RIZIV) updated “Low variability care” (APR-DRG) system for 2026. Overall, no significant changes were made to the system: no new DRGs were introduced, and tariffs remained nearly unchanged.

In 2026, the Dutch Healthcare Institute (ZIN) published the updated list of medical procedures reimbursed under basic health insurance with restrictions or limitations. The procedures have the so-called "claim" codes (aanspraakcodes). The Dutch Healthcare Authority assigns the "claim" codes based on positions published by the ZIN. The implemented changes included the introduction of two procedure codes for cryopreservation and storage of ovarian tissue.

In January 2026, the Budget Law 2026 entered into force in Italy, introducing healthcare-related measures, including provisions for National Health Fund financing, increased budgets for recruiting healthcare personnel, initiatives supporting prevention, research, as well as investments in regional healthcare services and digitalization.

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the December 2025 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Four favourable opinions were issued concerning add-on reimbursement for medical devices in the ENT, neuromodulation, and peripheral vascular fields.